Efficient priming of CD4+ and CD8+ T cells by DNA vaccination depends on appropriate targeting of sufficient levels of immunologically relevant antigen to appropriate processing pathways
- PMID: 12391208
- DOI: 10.4049/jimmunol.169.9.4951
Efficient priming of CD4+ and CD8+ T cells by DNA vaccination depends on appropriate targeting of sufficient levels of immunologically relevant antigen to appropriate processing pathways
Abstract
The initial cellular events and interactions that occur following DNA immunization are likely to be key to determining the character and magnitude of the resulting immune response, and as such, a better understanding of these events could ultimately lead to the design of more effective pathogen-appropriate DNA vaccines. Therefore, we have used a variety of sensitive cell-based techniques to study the induction of adaptive immunity in vivo. We examined the efficacy of induction of Ag-specific CD4(+) and CD8(+) T cell responses in vivo by the adoptive transfer of fluorescently labeled Ag-specific TCR transgenic T cells and have demonstrated how such approaches can be used to study the effect of simple DNA construct manipulations on immunological priming. OVA-specific CD8(+) and CD4(+) T cells were activated and divided in vivo following immunization with DNA constructs that targeted OVA expression to different subcellular locations; however, the kinetics and degree of cell proliferation were dependent on the cellular location of the expressed protein. DNA vectors encoding cell-associated OVA resulted in greater CD8(+) T cell division compared with other forms of OVA. In contrast, soluble secreted OVA targeted to the classical secretory pathway enhanced division of CD4(+) T cells. Furthermore, the inclusion of mammalian introns to enhance protein expression increased the ability of poorly immunogenic forms of Ag to activate naive T cells, indicating that not only the location, but also the amount of Ag expression, is important for efficient T cell priming following DNA injection.
Similar articles
-
DNA vaccines, combining form of antigen and method of delivery to raise a spectrum of IFN-gamma and IL-4-producing CD4+ and CD8+ T cells.J Immunol. 2003 Aug 15;171(4):1999-2005. doi: 10.4049/jimmunol.171.4.1999. J Immunol. 2003. PMID: 12902504
-
Prime-boost with alternating DNA vaccines designed to engage different antigen presentation pathways generates high frequencies of peptide-specific CD8+ T cells.J Immunol. 2006 Nov 15;177(10):6626-33. doi: 10.4049/jimmunol.177.10.6626. J Immunol. 2006. PMID: 17082574
-
CD63-Mediated Antigen Delivery into Extracellular Vesicles via DNA Vaccination Results in Robust CD8+ T Cell Responses.J Immunol. 2017 Jun 15;198(12):4707-4715. doi: 10.4049/jimmunol.1600731. Epub 2017 May 15. J Immunol. 2017. PMID: 28507029
-
DNA vaccination: the answer to stable, protective T-cell memory?Curr Opin Immunol. 2003 Aug;15(4):471-6. doi: 10.1016/s0952-7915(03)00068-2. Curr Opin Immunol. 2003. PMID: 12900281 Review.
-
Unravelling the mechanisms of help for CD8+ T cell responses.Immunol Res. 2009 Dec;45(2-3):209-17. doi: 10.1007/s12026-009-8102-0. Epub 2009 Feb 18. Immunol Res. 2009. PMID: 19224140 Review.
Cited by
-
Uptake and presentation of exogenous antigen and presentation of endogenously produced antigen by skin dendritic cells represent equivalent pathways for the priming of cellular immune responses following biolistic DNA immunization.Immunology. 2009 Sep;128(1 Suppl):e193-205. doi: 10.1111/j.1365-2567.2008.02947.x. Epub 2008 Sep 17. Immunology. 2009. PMID: 18800984 Free PMC article.
-
Multimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines.J Virol. 2006 Feb;80(4):1762-72. doi: 10.1128/JVI.80.4.1762-1772.2006. J Virol. 2006. PMID: 16439533 Free PMC article.
-
Optimization of codon usage enhances the immunogenicity of a DNA vaccine encoding mycobacterial antigen Ag85B.Infect Immun. 2005 Sep;73(9):5666-74. doi: 10.1128/IAI.73.9.5666-5674.2005. Infect Immun. 2005. PMID: 16113284 Free PMC article.
-
A detailed characterisation of the distribution and presentation of DNA vaccine encoded antigen.Vaccine. 2010 Feb 10;28(6):1620-34. doi: 10.1016/j.vaccine.2009.11.014. Epub 2009 Dec 23. Vaccine. 2010. PMID: 20035828 Free PMC article.
-
DNA vaccine encoding human immunodeficiency virus-1 Gag, targeted to the major histocompatibility complex II compartment by lysosomal-associated membrane protein, elicits enhanced long-term memory response.Immunology. 2004 May;112(1):126-33. doi: 10.1111/j.1365-2567.2004.01823.x. Immunology. 2004. PMID: 15129672 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials